Heritage Pharmaceuticals Inc
Heritage Pharmaceuticals Inc appears in FDA public data with 23 recalls — including 2 Class I (most serious) —, 0 510(k) clearances, 13 FDA inspections, and 1 compliance action on record. Its most recent recall (D-0768-2026, Class II) was initiated on Jul 30, 2026.
Summary
- Total Recalls
- 23 (2 Class I)
- 510(k) Clearances
- 0
- Inspections
- 13
- Compliance Actions
- 1
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0768-2026 | Class II | CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION, USP, 75 mg/5 mL, Rx Only, 100 mL, Distributed | Jul 30, 2026 |
| D-0109-2026 | Class II | Desipramine Hydrochloride Tablets, USP, 50 mg, 100 count bottle (NDC 23155-580-01), Rx only, Manufac | Oct 6, 2025 |
| D-0110-2026 | Class II | Desipramine Hydrochloride Tablets, USP, 75 mg, 100 count bottle (NDC 23155-581-01), Rx only, Manufac | Oct 6, 2025 |
| D-0108-2026 | Class II | Desipramine Hydrochloride Tablets, USP, 25 mg, 100 count bottle (NDC 23155-579-01), Rx only, Manufac | Oct 6, 2025 |
| D-0111-2026 | Class II | Desipramine Hydrochloride Tablets, USP, 100 mg, 100 count bottle (NDC 23155-582-01), Rx only, Manufa | Oct 6, 2025 |
| D-0112-2026 | Class II | Desipramine Hydrochloride Tablets, USP, 150 mg, 50 count bottle (NDC 23155-583-25), Rx only, Manufac | Oct 6, 2025 |
| D-0107-2026 | Class II | Desipramine Hydrochloride Tablets, USP, 10 mg, 100 - count bottle (NDC 23155-578-01), Rx only, Manuf | Oct 6, 2025 |
| D-0072-2023 | Class II | Desmopressin Acetate Tablets 0.2mg, 100-count bottles, RX Only, Distributed by: Avet Pharmaceuticals | Nov 23, 2022 |
| D-0367-2021 | Class III | Acyclovir Tablets, USP, 400 mg, 100 Tablets, Rx Only, Distributed by: Avet Pharmaceuticals Inc., Eas | Apr 21, 2021 |
| D-0108-2021 | Class III | Felodipine Extended Release Tablets, USP 10 mg,100-count bottle, Rx only, Distributed by: Heritage P | Oct 23, 2020 |
| D-1397-2019 | Class I | PROCHLORPERAZINE EDISYLATE INJECTION, USP 10 mg/2mL (5mg/mL), 2mL Vial, Rx Only, Mfg by: Emcure Phar | May 21, 2019 |
| D-1398-2019 | Class I | AMIKACIN SULFATE INJECTION, USP, 1 gram/4 mL (250 mg/ml), 4 mL vial, Rx only, Mfd. by: Emcure Pharma | May 21, 2019 |
| D-1287-2019 | Class II | Losartan Potassium Tablets, USP 50 mg 1000 film coated tablets Rx Only Manufactured by: Vivimed Lif | May 3, 2019 |
| D-1288-2019 | Class II | Losartan Potassium Tablets USP 100 mg 90 film coated tablets Manufactured by: Vivimed Life Science | May 3, 2019 |
| D-1289-2019 | Class II | Losartan Potassium Tablets USP 50 mg 90 film coated tablets Manufactured by: Vivimed Life Science | May 3, 2019 |
| D-1290-2019 | Class II | Losartan Potassium Tablets USP 100 mg 1000 film coated tablets Rx only Manufactured by: Vivimed | May 3, 2019 |
| D-1291-2019 | Class II | Losartan Potassium Tablets USP 25 mg 90 film coated tablets Rx Only Manufactured by: Vivimed Life | May 3, 2019 |
| D-1065-2019 | Class II | Etomidate Injection, USP 20 mg/10mL (2mg/mL) 10 mL Single-Dose Vial, Rx only, Manufactured for: Heri | Feb 15, 2019 |
| D-0352-2019 | Class II | Cidofovir Injection 375mg/5mL (75mg/mL) vial injection. 5 mL vials, Rx only, Mfd by: Emcure Pharmace | Jan 2, 2019 |
| D-0094-2019 | Class II | Cidofovir injection 375 mg/mL (75 mg/mL) vial Injection, 5 mL vials, Rx Only, Mfg. By Emcure Pharmac | Oct 15, 2018 |